A new era in signal detection
The launch of Eudravigilance, EMA’s database of adverse drug reactions, will grant the pharma industry access to a huge dataset of millions of case reports. Pharmathen’s...
The pros and cons of post-authorisation studies
Under European guidelines, all pharmaceutical products receiving or maintaining a marketing authorisation must go through a risk management plan that considers the safety and efficacy...
Pharmacovigilance: here to stay
Dr Dimitrios Antoniadis, EU-QPPV at Pharmathen, says that pharmacovigilance is a new contributor towards pharmaceutical innovation and research.
